Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
2 drugs in development
By Therapeutic Area
top 1
R&D Momentum
65/100
Pipeline Velocity
36/100
Trial Completion Rate
92/100
Pipeline Concentration
50/100
Pipeline Freshness
0/100
Strategic Signals
Activity
Last 14 days
Environment and Alcohol: A Pilot Study
Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl
SMART-r: Substance Monitoring and Active Relapse Tracking Repository
Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder
Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making
Cognitive Task Development and Implementation for Functional MRI Studies
Characterization of Phenotypic and Genotypic Regressors
Understanding the Acute Modulation of Brain Activity by Transcranial Magnetic Stimulation
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Regulatory
Parasal — PARASAL
Application NDA006811 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)